Gofen & Glossberg’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$6.12M Sell
104,185
-4,400
-4% -$278K 0.16% 124
2022
Q3
$6.21M Sell
108,585
-3,269
-3% -$191K 0.18% 117
2022
Q2
$6.06M Sell
111,854
-5,437
-5% -$316K 0.16% 119
2022
Q1
$6.74M Sell
117,291
-24,117
-17% -$1.23M 0.15% 121
2021
Q4
$6.69M Sell
141,408
-882
-0.6% -$40.2K 0.14% 124
2021
Q3
$5.99M Buy
142,290
+4,239
+3% +$183K 0.14% 131
2021
Q2
$6.12M Buy
138,051
+2,288
+2% +$106K 0.15% 127
2021
Q1
$6.33M Sell
135,763
-10,883
-7% -$481K 0.16% 124
2020
Q4
$5.68M Sell
146,646
-8,420
-5% -$301K 0.16% 119
2020
Q3
$4.47M Buy
155,066
+1,572
+1% +$44.3K 0.14% 126
2020
Q2
$4.11M Sell
153,494
-967
-0.6% -$25.2K 0.14% 123
2020
Q1
$3.63M Buy
154,461
+31,762
+26% +$873K 0.14% 119
2019
Q4
$3.63M Sell
122,699
-10,626
-8% -$281K 0.12% 127
2019
Q3
$3.73M Sell
133,325
-29,306
-18% -$847K 0.13% 123
2019
Q2
$4.81M Buy
+162,631
New +$4.38M 0.16% 118

Other funds holding CTVA

Gofen & Glossberg's CTVA Position: Q4 2022 in Review

Gofen & Glossberg reduced its Corteva (CTVA) stake by 4.1% in Q4 2022, selling an estimated $278K and leaving 104,185 shares worth $6.12M. The position accounts for 0.16% of the portfolio, ranked #124.

Gofen & Glossberg first reported a position in CTVA in Q2 2019 and has held it in 15 quarters since. The position peaked at $6.74M in Q1 2022. 1,302 funds tracked by Wall St. Rank hold CTVA as of Q4 2022.

  • Gofen & Glossberg held 104,185 shares of Corteva worth $6.12M as of Q4 2022.
  • Gofen & Glossberg sold 4,400 Corteva shares in Q4 2022, an estimated $278K.
  • Corteva made up 0.16% of Gofen & Glossberg's portfolio in Q4 2022, its #124 holding.
  • Gofen & Glossberg first reported a position in Corteva in Q2 2019 and has held it in 15 quarters since.
  • Gofen & Glossberg's Corteva position peaked at $6.74M in Q1 2022.
  • 1,302 funds tracked by Wall St. Rank held Corteva as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.